Helena Earl

nobleid.org/helenaearl

Breast Cancer Treatment Studies BRCA gene mutations in cancer Cancer Treatment and Pharmacology Breast Lesions and Carcinomas Gastric Cancer Management and Outcomes

Created: Nov 11, 2026

•Updated: Nov 11, 2026

Public URLs (2)

https://nobleid.org/NI4P81W98R77S82 https://nobleid.org/helenaearl

Affiliations

University of Cambridge

2019 - Present

Cancer Research UK Cambridge Center

2024 - Present

Cambridge University Hospitals NHS Foundation Trust

2024 - Present

NIHR Cambridge Biomedical Research Centre

2023 - Present

Addenbrooke's Hospital

2023 - Present

University of Birmingham

1992 - 1996

University College London Hospitals NHS Foundation Trust

1985 - 1992

Ludwig Institute for Cancer Research Ltd

1983 - 1985

Education & Qualifications

Royal College of Physicians, London

1997

Cited by

Measure	All
Citations	17,317
h-index	60
i10-index	162

As of Oct 14, 2026 · 362 works

Works (371)

334 on NobleID · 37 being added

Title	Cited by	Year
The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes Nature Communications	1,717	2016
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial The Lancet	1,657	2010
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the Inter European Journal of Heart Failure	815	2020
Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients Annals of Oncology	774	2014
Multi-omic machine learning predictor of breast cancer therapy response Nature	648	2021